TATDN3 antibody
Principal name
TATDN3 antibody
Alternative names for TATDN3 antibody
Putative deoxyribonuclease TATDN3
Ncbi ID
NP_001036017.1, ADR82915.1, NP_001036017, NM_001042552, NM_001042553, NM_001146169, NP_001036018, NP_001156894.1, NM_001163421, NM_001146170, NM_001163422, NM_001146171
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of TATDN3 antibody
- Kit Component:
- - KN317228G1, Tatdn3 gRNA vector 1 in pCas-Guide vector
- KN317228G2, Tatdn3 gRNA vector 2 in pCas-Guide vector
- KN317228D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Seim I., et al. (2008) BMC Mol Biol. 9:95.
Host: Rabbit; Target Name: TATDN3; Sample Tissue: ACHN Whole Cell lysates; Antibody Dilution: 1.0ug/ml
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP315613 | TATDN3 (transcript variant 2) |
||||
| Recombinant protein of human TatD DNase domain containing 3 (TATDN3), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY420981 | TATDN3 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY420982 | TATDN3 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY431198 | TATDN3 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216753L2V | Lenti ORF particles, Tatdn3 (GFP-tagged) - Mouse TatD DNase domain containing 3 (Tatdn3), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR218223L2V | Lenti ORF particles, Tatdn3 (GFP-tagged) - Mouse TatD DNase domain containing 3 (Tatdn3), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR216753L1V | Lenti ORF particles, Tatdn3 (Myc-DDK-tagged) - Mouse TatD DNase domain containing 3 (Tatdn3), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR218223L1V | Lenti ORF particles, Tatdn3 (Myc-DDK-tagged) - Mouse TatD DNase domain containing 3 (Tatdn3), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||